← All trials
NCT00297882
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2006
- Primary completion
- Apr 1, 2009
- Completion date
- Jul 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 900
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Bill and Melinda Gates FoundationLead sponsor
- Cameroon Baptist Convention HealthCollaborator
- Bill and Melinda Gates FoundationReponsible party - principal investigator
- University of YaoundeOverall official - principal investigator
- University of YaoundeCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.